TY - JOUR AU - Tsochatzis, E. A. AU - Bosch, J. AU - Burroughs, A. K. PY - 2014 DA - 2014// TI - Liver cirrhosis JO - Lancet (London, England) VL - 383 UR - https://doi.org/10.1016/S0140-6736(14)60121-5 DO - 10.1016/S0140-6736(14)60121-5 ID - Tsochatzis2014 ER - TY - JOUR AU - D'Amico, G. AU - Garcia-Tsao, G. AU - Pagliaro, L. PY - 2006 DA - 2006// TI - Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies JO - J Hepatol VL - 44 UR - https://doi.org/10.1016/j.jhep.2005.10.013 DO - 10.1016/j.jhep.2005.10.013 ID - D'Amico2006 ER - TY - JOUR AU - D'Amico, G. AU - Morabito, A. AU - D'Amico, M. AU - Pasta, L. AU - Malizia, G. AU - Rebora, P. PY - 2018 DA - 2018// TI - Clinical states of cirrhosis and competing risks JO - J Hepatol VL - 68 UR - https://doi.org/10.1016/j.jhep.2017.10.020 DO - 10.1016/j.jhep.2017.10.020 ID - D'Amico2018 ER - TY - JOUR AU - Younossi, Z. AU - Henry, L. PY - 2016 DA - 2016// TI - Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality JO - Gastroenterology. VL - 150 UR - https://doi.org/10.1053/j.gastro.2016.03.005 DO - 10.1053/j.gastro.2016.03.005 ID - Younossi2016 ER - TY - JOUR AU - Schuppan, D. AU - Afdhal, N. H. PY - 2008 DA - 2008// JO - Lancet (London, England) VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60383-9 DO - 10.1016/S0140-6736(08)60383-9 ID - Schuppan2008 ER - TY - JOUR AU - Chou, R. AU - Dana, T. AU - Blazina, I. AU - Daeges, M. AU - Jeanne, T. L. PY - 2016 DA - 2016// TI - Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US preventive services task force JO - JAMA. VL - 316 UR - https://doi.org/10.1001/jama.2015.15629 DO - 10.1001/jama.2015.15629 ID - Chou2016 ER - TY - JOUR AU - Oesterle, A. AU - Laufs, U. AU - Liao, J. K. PY - 2017 DA - 2017// TI - Pleiotropic effects of statins on the cardiovascular system JO - Circ Res VL - 120 UR - https://doi.org/10.1161/CIRCRESAHA.116.308537 DO - 10.1161/CIRCRESAHA.116.308537 ID - Oesterle2017 ER - TY - JOUR AU - Arab, J. P. AU - Shah, V. H. PY - 2016 DA - 2016// TI - Statins and portal hypertension: A tale of two models JO - Hepatology (Baltimore, Md) VL - 63 UR - https://doi.org/10.1002/hep.28567 DO - 10.1002/hep.28567 ID - Arab2016 ER - TY - JOUR AU - Meireles, C. Z. AU - Pasarin, M. AU - Lozano, J. J. AU - Garcia-Caldero, H. AU - Gracia-Sancho, J. AU - Garcia-Pagan, J. C. PY - 2017 DA - 2017// TI - Simvastatin Attenuates Liver Injury in Rodents with Biliary Cirrhosis Submitted to Hemorrhage/Resuscitation JO - Shock (Augusta, Ga) VL - 47 UR - https://doi.org/10.1097/SHK.0000000000000734 DO - 10.1097/SHK.0000000000000734 ID - Meireles2017 ER - TY - JOUR AU - Tripathi, D. M. AU - Vilaseca, M. AU - Lafoz, E. AU - Garcia-Caldero, H. AU - Viegas Haute, G. AU - Fernandez-Iglesias, A. PY - 2018 DA - 2018// TI - Simvastatin prevents progression of acute on chronic liver failure in rats with cirrhosis and portal hypertension JO - Gastroenterology. VL - 155 UR - https://doi.org/10.1053/j.gastro.2018.07.022 DO - 10.1053/j.gastro.2018.07.022 ID - Tripathi2018 ER - TY - JOUR AU - Vargas, J. I. AU - Arrese, M. AU - Shah, V. H. AU - Arab, J. P. PY - 2017 DA - 2017// TI - Use of statins in patients with chronic liver disease and cirrhosis: current views and prospects JO - Curr Gastroenterol Rep VL - 19 UR - https://doi.org/10.1007/s11894-017-0584-7 DO - 10.1007/s11894-017-0584-7 ID - Vargas2017 ER - TY - JOUR AU - Kamal, S. AU - Khan, M. A. AU - Seth, A. AU - Cholankeril, G. AU - Gupta, D. AU - Singh, U. PY - 2017 DA - 2017// TI - Beneficial effects of statins on the rates of hepatic fibrosis, hepatic Decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis JO - Am J Gastroenterol VL - 112 UR - https://doi.org/10.1038/ajg.2017.170 DO - 10.1038/ajg.2017.170 ID - Kamal2017 ER - TY - JOUR AU - Kim, R. G. AU - Loomba, R. AU - Prokop, L. J. AU - Singh, S. PY - 2017 DA - 2017// TI - Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis JO - Clin Gastroenterol Hepatol VL - 15 UR - https://doi.org/10.1016/j.cgh.2017.04.039 DO - 10.1016/j.cgh.2017.04.039 ID - Kim2017 ER - TY - JOUR AU - Pose, E. AU - Trebicka, J. AU - Mookerjee, R. P. AU - Angeli, P. AU - Gines, P. PY - 2019 DA - 2019// TI - Statins: old drugs as new therapy for liver diseases? JO - J Hepatol VL - 70 UR - https://doi.org/10.1016/j.jhep.2018.07.019 DO - 10.1016/j.jhep.2018.07.019 ID - Pose2019 ER - TY - JOUR AU - Kasia, C. AU - Scaglione, S. J. PY - 2019 DA - 2019// TI - Patients with chronic liver disease/cirrhosis should not take statin medications JO - Clin Liver Dis VL - 13 UR - https://doi.org/10.1002/cld.788 DO - 10.1002/cld.788 ID - Kasia2019 ER - TY - JOUR AU - Unger, L. W. AU - Forstner, B. AU - Schneglberger, S. AU - Muckenhuber, M. AU - Eigenbauer, E. AU - Bauer, D. PY - 2019 DA - 2019// TI - Guideline-conform statin use reduces overall mortality in patients with compensated liver disease JO - Sci Rep VL - 9 UR - https://doi.org/10.1038/s41598-019-47943-6 DO - 10.1038/s41598-019-47943-6 ID - Unger2019 ER - TY - JOUR AU - Patel, S. S. AU - Guzman, L. A. AU - Lin, F. P. AU - Pence, T. AU - Reichman, T. AU - John, B. PY - 2018 DA - 2018// TI - Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation JO - Liver Transpl VL - 24 UR - https://doi.org/10.1002/lt.25067 DO - 10.1002/lt.25067 ID - Patel2018 ER - TY - JOUR AU - Sigler, M. A. AU - Congdon, L. AU - Edwards, K. L. PY - 2018 DA - 2018// TI - An evidence-based review of statin use in patients with nonalcoholic fatty liver disease JO - Clin Med Insights Gastroenterol VL - 11 UR - https://doi.org/10.1177/1179552218787502 DO - 10.1177/1179552218787502 ID - Sigler2018 ER - TY - JOUR AU - Wright, A. P. AU - Adusumalli, S. AU - Corey, K. E. PY - 2015 DA - 2015// TI - Statin therapy in patients with cirrhosis JO - Frontline Gastroenterol VL - 6 UR - https://doi.org/10.1136/flgastro-2014-100500 DO - 10.1136/flgastro-2014-100500 ID - Wright2015 ER - TY - JOUR AU - Sirtori, C. R. PY - 2014 DA - 2014// TI - The pharmacology of statins JO - Pharmacol Res VL - 88 UR - https://doi.org/10.1016/j.phrs.2014.03.002 DO - 10.1016/j.phrs.2014.03.002 ID - Sirtori2014 ER - TY - JOUR AU - Abraldes, J. G. AU - Albillos, A. AU - Banares, R. AU - Turnes, J. AU - Gonzalez, R. AU - Garcia-Pagan, J. C. PY - 2009 DA - 2009// TI - Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial JO - Gastroenterol. VL - 136 UR - https://doi.org/10.1053/j.gastro.2009.01.043 DO - 10.1053/j.gastro.2009.01.043 ID - Abraldes2009 ER - TY - JOUR AU - Abraldes, J. G. AU - Villanueva, C. AU - Aracil, C. AU - Turnes, J. AU - Hernandez-Guerra, M. AU - Genesca, J. PY - 2016 DA - 2016// TI - Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis JO - Gastroenterol VL - 150 UR - https://doi.org/10.1053/j.gastro.2016.01.004 DO - 10.1053/j.gastro.2016.01.004 ID - Abraldes2016 ER - TY - JOUR AU - Bang, U. C. AU - Benfield, T. AU - Bendtsen, F. PY - 2017 DA - 2017// TI - Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study JO - Aliment Pharmacol Ther VL - 46 UR - https://doi.org/10.1111/apt.14243 DO - 10.1111/apt.14243 ID - Bang2017 ER - TY - JOUR AU - Bishnu, S. AU - Ahammed, S. M. AU - Sarkar, A. AU - Hembram, J. AU - Chatterjee, S. AU - Das, K. PY - 2018 DA - 2018// TI - Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study JO - Eur J Gastroenterol Hepatol VL - 30 UR - https://doi.org/10.1097/MEG.0000000000001006 DO - 10.1097/MEG.0000000000001006 ID - Bishnu2018 ER - TY - JOUR AU - Chang, F. M. AU - Wang, Y. P. AU - Lang, H. C. AU - Tsai, C. F. AU - Hou, M. C. AU - Lee, F. Y. PY - 2017 DA - 2017// TI - Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study JO - Hepatology (Baltimore, Md) VL - 66 UR - https://doi.org/10.1002/hep.29172 DO - 10.1002/hep.29172 ID - Chang2017 ER - TY - JOUR AU - Elwan, N. AU - Salah, R. AU - Hamisa, M. AU - Shady, E. AU - Hawash, N. AU - Abd-Elsalam, S. PY - 2018 DA - 2018// TI - Evaluation of portal pressure by doppler ultrasound in patients with cirrhosis before and after simvastatin administration - a randomized controlled trial JO - F1000Research VL - 7 UR - https://doi.org/10.12688/f1000research.13915.1 DO - 10.12688/f1000research.13915.1 ID - Elwan2018 ER - TY - JOUR AU - Huang, Y. W. AU - Lee, C. L. AU - Yang, S. S. AU - Fu, S. C. AU - Chen, Y. Y. AU - Wang, T. C. PY - 2017 DA - 2017// TI - Statins reduce the risk of cirrhosis and its Decompensation in chronic hepatitis B patients: a Nationwide cohort study JO - Am J Gastroenterol VL - 111 UR - https://doi.org/10.1038/ajg.2016.179 DO - 10.1038/ajg.2016.179 ID - Huang2017 ER - TY - JOUR AU - Kaplan, D. E. AU - Serper, M. A. AU - Mehta, R. AU - Fox, R. AU - John, B. AU - Aytaman, A. PY - 2019 DA - 2019// TI - Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis JO - Gastroenterology VL - 156 UR - https://doi.org/10.1053/j.gastro.2019.01.026 DO - 10.1053/j.gastro.2019.01.026 ID - Kaplan2019 ER - TY - JOUR AU - Kim, G. AU - Jang, S. Y. AU - Nam, C. M. AU - Kang, E. S. PY - 2018 DA - 2018// TI - Statin use and the risk of hepatocellular carcinoma in patients at high risk: a nationwide nested case-control study JO - J Hepatol VL - 68 UR - https://doi.org/10.1016/j.jhep.2017.10.018 DO - 10.1016/j.jhep.2017.10.018 ID - Kim2018 ER - TY - JOUR AU - Kumar, S. AU - Grace, N. D. AU - Qamar, A. A. PY - 2014 DA - 2014// TI - Statin use in patients with cirrhosis: a retrospective cohort study JO - Dig Dis Sci VL - 59 UR - https://doi.org/10.1007/s10620-014-3179-2 DO - 10.1007/s10620-014-3179-2 ID - Kumar2014 ER - TY - JOUR AU - Mohanty, A. AU - Tate, J. P. AU - Garcia-Tsao, G. PY - 2016 DA - 2016// TI - Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis JO - Gastroenterology VL - 150 UR - https://doi.org/10.1053/j.gastro.2015.10.007 DO - 10.1053/j.gastro.2015.10.007 ID - Mohanty2016 ER - TY - JOUR AU - Pollo-Flores, P. AU - Soldan, M. AU - Santos, U. C. AU - Kunz, D. G. AU - Mattos, D. E. AU - Silva, A. C. PY - 2015 DA - 2015// TI - Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: a randomized controlled trial JO - Dig Liver Dis VL - 47 UR - https://doi.org/10.1016/j.dld.2015.07.156 DO - 10.1016/j.dld.2015.07.156 ID - Pollo-Flores2015 ER - TY - JOUR AU - Simon, T. G. AU - Bonilla, H. AU - Yan, P. AU - Chung, R. T. AU - Butt, A. A. PY - 2016 DA - 2016// TI - Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES JO - Hepatology (Baltimore, Md) VL - 64 UR - https://doi.org/10.1002/hep.28506 DO - 10.1002/hep.28506 ID - Simon2016 ER - TY - JOUR AU - Simon, T. G. AU - King, L. Y. AU - Zheng, H. AU - Chung, R. T. PY - 2015 DA - 2015// TI - Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C JO - J Hepatol VL - 62 UR - https://doi.org/10.1016/j.jhep.2014.08.013 DO - 10.1016/j.jhep.2014.08.013 ID - Simon2015 ER - TY - JOUR AU - Wani, Z. A. AU - Mohapatra, S. AU - Khan, A. A. AU - Mohapatra, A. AU - Yatoo, G. N. PY - 2017 DA - 2017// TI - Addition of simvastatin to carvedilol non responders: a new pharmacological therapy for treatment of portal hypertension JO - World J Hepatol VL - 9 UR - https://doi.org/10.4254/wjh.v9.i5.270 DO - 10.4254/wjh.v9.i5.270 ID - Wani2017 ER - TY - JOUR AU - Wong, J. C. AU - Chan, H. L. AU - Tse, Y. K. AU - Yip, T. C. AU - Wong, V. W. AU - Wong, G. L. PY - 2017 DA - 2017// TI - Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis JO - Aliment Pharmacol Ther VL - 46 UR - https://doi.org/10.1111/apt.14341 DO - 10.1111/apt.14341 ID - Wong2017 ER - TY - JOUR AU - Yang, Y. H. AU - Chen, W. C. AU - Tsan, Y. T. AU - Chen, M. J. AU - Shih, W. T. AU - Tsai, Y. H. PY - 2015 DA - 2015// TI - Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection JO - J Hepatol VL - 63 UR - https://doi.org/10.1016/j.jhep.2015.07.006 DO - 10.1016/j.jhep.2015.07.006 ID - Yang2015 ER - TY - JOUR AU - Shamseer, L. AU - Moher, D. AU - Clarke, M. AU - Ghersi, D. AU - Liberati, A. AU - Petticrew, M. PY - 2015 DA - 2015// TI - Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation JO - BMJ (Clinical research ed) VL - 350 ID - Shamseer2015 ER - TY - JOUR PY - 2019 DA - 2019// TI - Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials JO - Lancet (London, England) VL - 393 UR - https://doi.org/10.1016/S0140-6736(18)31942-1 DO - 10.1016/S0140-6736(18)31942-1 ID - ref39 ER - TY - JOUR AU - Wan, S. AU - Huang, C. AU - Zhu, X. PY - 2019 DA - 2019// TI - Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients JO - BMJ Open VL - 9 UR - https://doi.org/10.1136/bmjopen-2019-030038 DO - 10.1136/bmjopen-2019-030038 ID - Wan2019 ER - TY - JOUR AU - Choi, H. D. AU - Chae, S. M. PY - 2018 DA - 2018// TI - Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia: a systematic review and meta-analysis JO - Medicine. VL - 97 UR - https://doi.org/10.1097/MD.0000000000013593 DO - 10.1097/MD.0000000000013593 ID - Choi2018 ER - TY - JOUR AU - He, Y. AU - Li, X. AU - Gasevic, D. AU - Brunt, E. AU - McLachlan, F. AU - Millenson, M. PY - 2018 DA - 2018// TI - Statins and multiple noncardiovascular outcomes: umbrella review of meta-analyses of observational studies and randomized controlled trials JO - Ann Intern Med VL - 169 UR - https://doi.org/10.7326/M18-0808 DO - 10.7326/M18-0808 ID - He2018 ER - TY - JOUR AU - Ma, X. AU - Sun, D. AU - Li, C. AU - Ying, J. AU - Yan, Y. PY - 2017 DA - 2017// TI - Statin use and virus-related cirrhosis: a systemic review and meta-analysis JO - Clin Res Hepatol Gastroenterol VL - 41 UR - https://doi.org/10.1016/j.clinre.2017.07.004 DO - 10.1016/j.clinre.2017.07.004 ID - Ma2017 ER - TY - JOUR AU - Naci, H. AU - Brugts, J. AU - Ades, T. PY - 2013 DA - 2013// TI - Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials JO - Circ Cardiovasc Qual Outcomes VL - 6 UR - https://doi.org/10.1161/CIRCOUTCOMES.111.000071 DO - 10.1161/CIRCOUTCOMES.111.000071 ID - Naci2013 ER - TY - JOUR AU - Ascione, A. AU - Fontanella, L. AU - Imparato, M. AU - Rinaldi, L. AU - Luca, M. PY - 2017 DA - 2017// TI - Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years JO - Liver Int VL - 37 UR - https://doi.org/10.1111/liv.13371 DO - 10.1111/liv.13371 ID - Ascione2017 ER - TY - JOUR AU - Llovet, J. M. AU - Burroughs, A. AU - Bruix, J. PY - 2003 DA - 2003// TI - Hepatocellular carcinoma JO - Lancet (London, England) VL - 362 UR - https://doi.org/10.1016/S0140-6736(03)14964-1 DO - 10.1016/S0140-6736(03)14964-1 ID - Llovet2003 ER - TY - JOUR AU - Thompson, P. D. AU - Panza, G. AU - Zaleski, A. AU - Taylor, B. PY - 2016 DA - 2016// TI - Statin-associated side effects JO - J Am Coll Cardiol VL - 67 UR - https://doi.org/10.1016/j.jacc.2016.02.071 DO - 10.1016/j.jacc.2016.02.071 ID - Thompson2016 ER - TY - JOUR AU - Baspinar, O. AU - Bayram, F. AU - Korkmaz, S. AU - Aksu, M. AU - Kocer, D. AU - Dizdar, O. S. PY - 2016 DA - 2016// TI - The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin JO - J Clin Lipidol VL - 10 UR - https://doi.org/10.1016/j.jacl.2016.09.004 DO - 10.1016/j.jacl.2016.09.004 ID - Baspinar2016 ER - TY - JOUR AU - Forstermann, U. AU - Sessa, W. C. PY - 2012 DA - 2012// TI - Nitric oxide synthases: regulation and function JO - Eur Heart J VL - 33 UR - https://doi.org/10.1093/eurheartj/ehr304 DO - 10.1093/eurheartj/ehr304 ID - Forstermann2012 ER - TY - JOUR AU - Vincenzo, L. M. AU - Marcos, P. AU - Meireles, C. Z. AU - Rosa, M. AU - Aina, R. V. AU - Diana, H. PY - 2013 DA - 2013// TI - Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction JO - Hepatology (Baltimore, Md) VL - 57 UR - https://doi.org/10.1002/hep.26127 DO - 10.1002/hep.26127 ID - Vincenzo2013 ER - TY - JOUR AU - Trocha, M. AU - Merwid-Lad, A. AU - Szuba, A. AU - Chlebda, E. AU - Piesniewska, M. AU - Sozanski, T. PY - 2010 DA - 2010// TI - Effect of simvastatin on nitric oxide synthases (eNOS, iNOS) and arginine and its derivatives (ADMA, SDMA) in ischemia/reperfusion injury in rat liver JO - Pharmacol Rep VL - 62 UR - https://doi.org/10.1016/S1734-1140(10)70274-7 DO - 10.1016/S1734-1140(10)70274-7 ID - Trocha2010 ER - TY - JOUR AU - Zafra, C. AU - Abraldes, J. G. AU - Turnes, J. AU - Berzigotti, A. AU - Fernandez, M. AU - Garca-Pagan, J. C. PY - 2004 DA - 2004// TI - Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis JO - Gastroenterology. VL - 126 UR - https://doi.org/10.1053/j.gastro.2003.12.007 DO - 10.1053/j.gastro.2003.12.007 ID - Zafra2004 ER - TY - JOUR AU - Costa, S. AU - Reina-Couto, M. AU - Albino-Teixeira, A. AU - Sousa, T. PY - 2016 DA - 2016// TI - Statins and oxidative stress in chronic heart failure JO - Rev Port Cardiol VL - 35 UR - https://doi.org/10.1016/j.repc.2015.09.006 DO - 10.1016/j.repc.2015.09.006 ID - Costa2016 ER - TY - JOUR AU - Lee, S. H. AU - Choi, N. Y. AU - Yu, H. J. AU - Park, J. AU - Choi, H. AU - Lee, K. Y. PY - 2016 DA - 2016// TI - Atorvastatin protects NSC-34 motor neurons against oxidative stress by activating PI3K, ERK and free radical scavenging JO - Mol Neurobiol VL - 53 UR - https://doi.org/10.1007/s12035-014-9030-0 DO - 10.1007/s12035-014-9030-0 ID - Lee2016 ER - TY - JOUR AU - Athyros, V. G. AU - Alexandrides, T. K. AU - Bilianou, H. AU - Cholongitas, E. AU - Doumas, M. AU - Ganotakis, E. S. PY - 2017 DA - 2017// TI - The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An expert panel statement JO - Metab Clin Exp VL - 71 UR - https://doi.org/10.1016/j.metabol.2017.02.014 DO - 10.1016/j.metabol.2017.02.014 ID - Athyros2017 ER - TY - JOUR AU - Schierwagen, R. AU - Uschner, F. E. AU - Magdaleno, F. AU - Klein, S. AU - Trebicka, J. PY - 2017 DA - 2017// TI - Rationale for the use of statins in liver disease JO - Am J Physiol Gastrointest Liver Physiol VL - 312 UR - https://doi.org/10.1152/ajpgi.00441.2016 DO - 10.1152/ajpgi.00441.2016 ID - Schierwagen2017 ER - TY - JOUR AU - Chen, Z. AU - Yu, R. AU - Xiong, Y. AU - Du, F. AU - Zhu, S. PY - 2017 DA - 2017// TI - A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease JO - Lipids Health Dis VL - 16 UR - https://doi.org/10.1186/s12944-017-0572-9 DO - 10.1186/s12944-017-0572-9 ID - Chen2017 ER - TY - JOUR AU - Franceschini, L. AU - Realdon, S. AU - Marcolongo, M. AU - Mirandola, S. AU - Bortoletto, G. AU - Alberti, A. PY - 2011 DA - 2011// TI - Reciprocal interference between insulin and interferon-alpha signaling in hepatic cells: a vicious circle of clinical significance? JO - Hepatology (Baltimore, Md) VL - 54 UR - https://doi.org/10.1002/hep.24394 DO - 10.1002/hep.24394 ID - Franceschini2011 ER - TY - JOUR AU - Zhao, T. Y. AU - Su, L. P. AU - Ma, C. Y. AU - Zhai, X. H. AU - Duan, Z. J. AU - Zhu, Y. PY - 2015 DA - 2015// TI - IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats JO - BMC Gastroenterol VL - 15 UR - https://doi.org/10.1186/s12876-015-0311-5 DO - 10.1186/s12876-015-0311-5 ID - Zhao2015 ER - TY - JOUR AU - Fattovich, G. AU - Stroffolini, T. AU - Zagni, I. AU - Donato, F. PY - 2004 DA - 2004// TI - Hepatocellular carcinoma in cirrhosis: incidence and risk factors JO - Gastroenterology. VL - 127 UR - https://doi.org/10.1053/j.gastro.2004.09.014 DO - 10.1053/j.gastro.2004.09.014 ID - Fattovich2004 ER - TY - JOUR AU - Barbarash, O. AU - Gruzdeva, O. AU - Uchasova, E. AU - Belik, E. AU - Dyleva, Y. AU - Karetnikova, V. PY - 2015 DA - 2015// TI - Dose-dependent effects of atorvastatin on myocardial infarction JO - Drug Des Devel Ther VL - 9 ID - Barbarash2015 ER - TY - JOUR AU - Henein, M. AU - Granasen, G. AU - Wiklund, U. AU - Schmermund, A. AU - Guerci, A. AU - Erbel, R. PY - 2015 DA - 2015// TI - High dose and long-term statin therapy accelerate coronary artery calcification JO - Int J Cardiol VL - 184 UR - https://doi.org/10.1016/j.ijcard.2015.02.072 DO - 10.1016/j.ijcard.2015.02.072 ID - Henein2015 ER -